2-methyl-3-[(piperidin-4-yl)oxy]-pyridine | 900511-88-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-methyl-3-[(piperidin-4-yl)oxy]-pyridine
• 英文别名: 2-Methyl-3-(piperidin-4-yloxy)pyridine；2-methyl-3-piperidin-4-yloxypyridine
• CAS: 900511-88-8
• 化学式: C₁₁H₁₆N₂O
• 分子量: 192.261
• InChiKey: YSRXVYOLINGXBB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  34.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-methyl-3-[(piperidin-4-yl)oxy]-pyridine 、 5-异硫代氰酰基-2-甲氧基吡啶 以 二氯甲烷 为溶剂， 反应 72.0h， 以48%的产率得到N-(6-methoxypyridin-3-yl)-4-[(2-methylpyridin-3-yl)oxy]piperidine-1-carbothioamide
  参考文献：
  名称：

  Substituted triazole derivatives as oxytocin antagonists

  摘要：

  本发明涉及公式（I）的取代三唑化合物，其用途，制备方法以及含有该化合物的组合物。这些抑制剂在包括性功能障碍在内的各种治疗领域具有用途。

  公开号：

  US20060160786A1
• 作为产物：
  描述：

  3-[(1-benzylpiperidin-4-yl)oxy]-2-methyl-pyridine 在 palladium 10% on activated carbon 氢气 作用下， 以 乙醇 、 水 为溶剂， 60.0 ℃ 、413.69 kPa 条件下， 反应 36.0h， 以74%的产率得到2-methyl-3-[(piperidin-4-yl)oxy]-pyridine
  参考文献：
  名称：

  Substituted triazole derivatives as oxytocin antagonists

  摘要：

  本发明涉及公式（I）的取代三唑化合物，其用途，制备方法以及含有该化合物的组合物。这些抑制剂在包括性功能障碍在内的各种治疗领域具有用途。

  公开号：

  US20060160786A1

文献信息

• GUANIDINE COMPOUND
  申请人：Astellas Pharma Inc.

  公开号：US20130143860A1

  公开（公告）日：2013-06-06

  [Problem] The present invention provides a compound which is useful as an active ingredient of a pharmaceutical composition, in particular, a pharmaceutical composition for preventing and/or treating VAP-1-related diseases. [Means for Solution] The present inventors have conducted intensive studies on a compound having a VAP-1 inhibitory activity, and as a result, they have found that the compound or a salt thereof of the present invention exhibits an excellent VAP-1 inhibitory activity and is useful for preventing and/or treating VAP-1-related diseases, in particular, diabetic nephropathy or diabetic macular edema, thereby completing the present invention. In addition, the present invention relates to a pharmaceutical composition, in particular, a pharmaceutical composition for preventing and/or treating VAP-1-related diseases, which comprises the compound or a salt thereof of the present invention, and an excipient.

  [问题]本发明提供一种化合物，用作药物组合物的活性成分，特别是用于预防和/或治疗与VAP-1相关的疾病的药物组合物。 [解决方法]本发明人对具有VAP-1抑制活性的化合物进行了深入研究，结果发现本发明的化合物或其盐表现出优异的VAP-1抑制活性，可用于预防和/或治疗与VAP-1相关的疾病，特别是糖尿病肾病或糖尿病黄斑水肿，从而完成了本发明。此外，本发明涉及一种药物组合物，特别是用于预防和/或治疗与VAP-1相关的疾病的药物组合物，其包括本发明的化合物或其盐和赋形剂。
• Substituted Triazole Derivatives As Oxytocin Antagonists
  申请人：Brown Alan Daniel

  公开号：US20090253674A1

  公开（公告）日：2009-10-08

  The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.

  本发明涉及公式(I)的取代三唑，其用途、制备过程和含有该化合物的组合物。这些抑制剂在包括性功能障碍在内的多种治疗领域中具有实用性。
• Guanidine compound
  申请人：Astellas Pharma Inc.

  公开号：US09051283B2

  公开（公告）日：2015-06-09

  [Problem] The present invention provides a compound which is useful as an active ingredient of a pharmaceutical composition, in particular, a pharmaceutical composition for preventing and/or treating VAP-1-related diseases. [Means for Solution] The present inventors have conducted intensive studies on a compound having a VAP-1 inhibitory activity, and as a result, they have found that the compound or a salt thereof of the present invention exhibits an excellent VAP-1 inhibitory activity and is useful for preventing and/or treating VAP-1-related diseases, in particular, diabetic nephropathy or diabetic macular edema, thereby completing the present invention. In addition, the present invention relates to a pharmaceutical composition, in particular, a pharmaceutical composition for preventing and/or treating VAP-1-related diseases, which comprises the compound or a salt thereof of the present invention, and an excipient.

  [问题]本发明提供了一种化合物，该化合物可用作制药组合物的活性成分，特别是用于预防和/或治疗VAP-1相关疾病的制药组合物。 [解决方案]本发明人对具有VAP-1抑制活性的化合物进行了深入研究，结果发现本发明的该化合物或其盐具有出色的VAP-1抑制活性，并且对于预防和/或治疗VAP-1相关疾病，特别是糖尿病肾病或糖尿病黄斑水肿非常有用，从而完成了本发明。此外，本发明涉及一种制药组合物，特别是用于预防和/或治疗VAP-1相关疾病的制药组合物，其包括本发明的该化合物或其盐以及赋形剂。
• SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS
  申请人：Ixchelsis Limited

  公开号：US20150322042A1

  公开（公告）日：2015-11-12

  The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.

  本发明涉及式(I)的取代三唑，以及其用途、制备过程和含有该化合物的组合物。这些抑制剂在包括性功能障碍在内的各种治疗领域中具有实用性。
• US7557131B2
  申请人：——

  公开号：US7557131B2

  公开（公告）日：2009-07-07